TrialLancet (London, England)2021
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Merryn Voysey et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2,920 papers cite itlatest 60 shown
this paperpooled ittrialcites it